Biomarkers in spinal cord injury

[1] Bracken MB(1997)Administration of methylprednisolone for 24 or 48 h or tirilazad mesylate for 48 h in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study JAMA 277 1597-1604

[2] Shepard MJ(2002)Immediate spinal cord decompression for cervical spinal cord injury: feasibility and outcome J Trauma 52 323-332

[3] Holford TR(2007)Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures Spinal Cord 45 206-221

[4] Leo-Summers L(1992)Prognostic significance of magnetic resonance imaging in the acute phase of cervical spine injury J Neurosurg 76 218-223

[5] Aldrich EF(2007)Neuroimaging in traumatic spinal cord injury: an evidence-based review for clinical practice and research J Spinal Cord Med 30 205-214

[6] Fazl M(1991)The 72-h examination as a predictor of recovery in motor complete quadriplegia Arch Phys Med Rehabil 72 546-548

[7] Papadopoulos SM(2004)Metric properties of the ASIA motor score: subscales improve correlation with functional activities Arch Phys Med Rehabil 85 1804-1810

[8] Selden NR(1996)Forecasting motor recovery after cervical spinal cord injury: value of MR imaging Radiology 201 649-655

[9] Quint DJ(2007)Acute cervical traumatic spinal cord injury: MR imaging findings correlated with neurologic outcome—prospective study with 100 consecutive patients Radiology 243 820-827

[10] Patel N(1986)Determination in human cerebrospinal fluid of glial fibrillary acidic protein, S-100 and myelin basic protein as indices of non-specific or specific central nervous tissue pathology Clin Chim Acta 155 143-150

[1] Bracken MB(1997)Administration of methylprednisolone for 24 or 48 h or tirilazad mesylate for 48 h in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study JAMA 277 1597-1604

[2] Shepard MJ(2002)Immediate spinal cord decompression for cervical spinal cord injury: feasibility and outcome J Trauma 52 323-332

[3] Holford TR(2007)Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures Spinal Cord 45 206-221

[4] Leo-Summers L(1992)Prognostic significance of magnetic resonance imaging in the acute phase of cervical spine injury J Neurosurg 76 218-223

[5] Aldrich EF(2007)Neuroimaging in traumatic spinal cord injury: an evidence-based review for clinical practice and research J Spinal Cord Med 30 205-214

[6] Fazl M(1991)The 72-h examination as a predictor of recovery in motor complete quadriplegia Arch Phys Med Rehabil 72 546-548

[7] Papadopoulos SM(2004)Metric properties of the ASIA motor score: subscales improve correlation with functional activities Arch Phys Med Rehabil 85 1804-1810

[8] Selden NR(1996)Forecasting motor recovery after cervical spinal cord injury: value of MR imaging Radiology 201 649-655

[9] Quint DJ(2007)Acute cervical traumatic spinal cord injury: MR imaging findings correlated with neurologic outcome—prospective study with 100 consecutive patients Radiology 243 820-827

[10] Patel N(1986)Determination in human cerebrospinal fluid of glial fibrillary acidic protein, S-100 and myelin basic protein as indices of non-specific or specific central nervous tissue pathology Clin Chim Acta 155 143-150